HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability

Cited by (957)

Items 301–400 of 957

  1. Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy
    Zhangyi Luo, Katherine Marie Eichinger, Anju Zhang, Song Li · 2023 · Cancer Letters
  2. Hypoxia-inducible Factor Prolyl-4-hydroxylase PHD2 Protein Abundance Depends on Integral Membrane Anchoring of FKBP38
    Sandra Barth, Frank Edlich, Utta Berchner‐Pfannschmidt, Silke Gneuss, Günther Jahreis, Philippe A. Hasgall, Joachim Fandrey, Roland H. Wenger, Gieri Camenisch · 2009 · Journal of Biological Chemistry
  3. Targeting the Met signaling pathway in renal cancer
    Alessio Giubellino, William Marston Linehan, Donald Paul Bottaro · 2009 · Expert Review of Anticancer Therapy
  4. Metabolic Pathways in Kidney Cancer: Current Therapies and Future Directions
    W. Kimryn Rathmell, Jeffrey C. Rathmell, William Marston Linehan · 2018 · Journal of Clinical Oncology
  5. HIF and fumarate hydratase in renal cancer
    Sunil Sudarshan, William Marston Linehan, Len Neckers · 2007 · British Journal of Cancer
  6. Mechanism of Cancer Cell Adaptation to Metabolic Stress
    Rui R Liu, Zhenjun Li, Shujun Bai, Haiyuan Zhang, Minghai Tang, Yunlong Lei, Lijuan Chen, Shufang Liang, Yinglan Zhao, Yuquan Wei et al. · 2008 · Molecular & Cellular Proteomics
  7. Metabolic Alterations in Pancreatic Cancer Progression
    Enza Vernucci, Jaime Abrego, Venugopal Gunda, Surendra Kumar Shukla, Aneesha Dasgupta, Vikrant Rai, Nina V. Chaika, Kyla B. Buettner, Alysha L. Illies, Fang Yu et al. · 2019 · Cancers
  8. The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy
    Hoerner, Christian R., Chen, Viola J., Fan, Alice C. · 2019 · Kidney Cancer
  9. Metabolic features of clear-cell renal cell carcinoma: mechanisms and clinical implications
    Jehonathan H. Pinthus, Kaitlyn F. Whelan, Daniel Gallino, Jianping Lu, Nathan Rothschild · 2011 · Canadian Urological Association Journal
  10. Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase
    Soohwan Yum, Seongkeun Jeong, Do‐Hoon Kim, Sunyoung Lee, Wooseong Kim, Jin‐Wook Yoo, Jung‐Ae Kim, Ohsang Kwon, Dae‐Duk Kim, Do Sik Min et al. · 2017 · International Journal of Molecular Sciences
  11. SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling
    Kaelin, William G. · 2009 · Cancer Cell
  12. Metabolic switches during development and regeneration
    Ahmed I. Mahmoud · 2023 · Development
  13. Enzymatic features of the glucose metabolism in tumor cells
    Anique Herling, Matthias König, Sascha Bulik, Hermann−Georg Holzhütter · 2011 · FEBS Journal
  14. Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype
    Su Yeon Lee, Min Kyung Ju, Hyun Min Jeon, Yig Ji Lee, Cho Hee Kim, Hye Gyeong Park, Song Iy Han, Ho Sung Kang · 2018 · Oxidative Medicine and Cellular Longevity
  15. Mito-Nuclear Communication by Mitochondrial Metabolites and Its Regulation by B-Vitamins
    Joëlle J. E. Janssen, Sander Grefte, Jaap Keijer, Vincent C. J. de Boer · 2019 · Frontiers in Physiology
  16. San-Huang-Yi-Shen Capsule Ameliorates Diabetic Nephropathy in Rats Through Modulating the Gut Microbiota and Overall Metabolism
    Xiuhai Su, Wenxia Yu, Airu Liu, Congxiang Wang, Xiuzhen Li, Juanjuan Gao, Xiao-Fei Liu, Wenhui Jiang, Yue Yang, Shuquan Lv · 2022 · Frontiers in Pharmacology
  17. Cellular oxygen sensing in health and disease
    David Robert Mole, Peter John Ratcliffe · 2007 · Pediatric Nephrology
  18. Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma
    Katarína Kľučková, Daniel A. Tennant · 2018 · Cell and Tissue Research
  19. Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy
    Elizabeth Cartwright Pfaffenroth, William Marston Linehan · 2008 · Expert Opinion on Biological Therapy
  20. Loss of HIF-1α impairs GLUT4 translocation and glucose uptake by the skeletal muscle cells
    Hidemitsu Sakagami, Yuichi Makino, Katsutoshi Mizumoto, Tsubasa Isoe, Yasutaka Takeda, Jun Watanabe, Yukihiro Fujita, Yumi Takiyama, Atsuko Abiko, Masakazu Haneda · 2014 · American Journal of Physiology-Endocrinology and Metabolism
  21. Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy
    Sebastiano Buti, Alessandro Leonetti, Alice Dallatomasina, Melissa Bersanelli · 2016 · Core evidence
  22. Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism
    Patrick J. Pollard, Ming Hui Yang, Huizhong Su, Tomoyoshi Soga, Kamil R. Kranc · 2014 · Hypoxia
  23. The role of mitochondrial electron transport in tumorigenesis and metastasis
    An S. Tan, James W. Baty, Michael V. Berridge · 2013 · Biochimica et Biophysica Acta (BBA) - General Subjects
  24. Metabolic synthetic lethality in cancer therapy
    Vincent Roberto Zecchini, Christian Frezza · 2016 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
  25. Biomaterial‐Based Metabolic Regulation in Regenerative Engineering
    Chuying Ma, Michelle L. Kuzma, Xiaochun Bai, Jian Yu Yang · 2019 · Advanced Science
  26. Mechanisms of Disease: hereditary leiomyomatosis and renal cell cancer—a distinct form of hereditary kidney cancer
    Sunil Sudarshan, Peter A. Pinto, Len Neckers, William Marston Linehan · 2007 · Nature Clinical Practice Urology
  27. Hypoxic Regulation of Gene Transcription and Chromatin: Cause and Effect
    Jessica D. Kindrick, David Robert Mole · 2020 · International Journal of Molecular Sciences
  28. The role of the metabolite cargo of extracellular vesicles in tumor progression
    Mária Harmati, Mátyás Bukva, Tímea Böröczky, Krisztina Buzás, Edina Gyukity-Sebestyén · 2021 · Cancer and Metastasis Reviews
  29. Role of Mitochondrial Stress Response in Cancer Progression
    Yu Geon Lee, Do Hong Park, Young Chan Chae · 2022 · Cells
  30. HIF, a missing link between metabolism and cancer
    Miguel Angel Esteban, Patrick Henry Maxwell · 2005 · Nature Medicine
  31. New Insights into the Biology of Renal Cell Carcinoma
    Lianjie Li, William G. Kaelin · 2011 · Hematology/Oncology Clinics of North America
  32. Upregulation of Hypoxia-Inducible Factor (HIF)-1α and HIF-2α in Leptomeningeal Vascular Malformations of Sturge-Weber Syndrome
    Amina Comati, Heike Beck, WILLIAM C. HALLIDAY, G. Jackson Snipes, Karl Heinz Plate, Till Acker · 2007 · Journal of Neuropathology & Experimental Neurology
  33. Hereditary Renal Cell Carcinoma Syndromes
    Adebowale Adeniran, Brian M. Shuch, Peter A. Humphrey · 2015 · The American Journal of Surgical Pathology
  34. Cancer-associated 2-oxoglutarate analogues modify histone methylation by inhibiting histone lysine demethylases
    Tuomas Laukka, Matti Myllykoski, Ryan Looper, Peppi Koivunen · 2018 · Journal of Molecular Biology
  35. Nutritional Exchanges Within Tumor Microenvironment: Impact for Cancer Aggressiveness
    Giuseppina Comito, Luigi Ippolito, Paola Chiarugi, Paolo Cirri · 2020 · Frontiers in Oncology
  36. The Oncometabolite Fumarate Promotes Pseudohypoxia Through Noncanonical Activation of NF-κB Signaling
    Karthigayan Shanmugasundaram, Bijaya Nayak, Eun‐Hee Shim, Carolina Becker Livi, Karen L. Block, Sunil Sudarshan · 2014 · Journal of Biological Chemistry
  37. Reporter Ligand NMR Screening Method for 2-Oxoglutarate Oxygenase Inhibitors
    Ivanhoe K. H. Leung, Marina Demetriades, A. Hardy, Clarisse Lejeune, Tristan J. Smart, Andrea Szöllössi, Akane Kawamura, Christopher John Schofield, Timothy D. W. Claridge · 2012 · Journal of Medicinal Chemistry
  38. The Mitochondrial Respiratory Chain Is Required for Organismal Adaptation to Hypoxia
    Robert B. Hamanaka, Samuel Edward Weinberg, Colleen R. Reczek, Navdeep S. Chandel · 2016 · Cell Reports
  39. Fumarate Hydratase Deletion in Pancreatic β Cells Leads to Progressive Diabetes
    Julie Adam, Reshma D. Ramracheya, Margarita V. Chibalina, Nicola Ternette, Alexander Hamilton, Andrei I. Tarasov, Quan Zhang, Eduardo Rebelato, Nils J. G. Rorsman, Rafael Martín-del-Río et al. · 2017 · Cell Reports
  40. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma–paraganglioma syndromes characterized by germline SDHB and SDHD mutations
    Bora E. Baysal, Eamonn Richard Maher · 2015 · Endocrine Related Cancer
  41. Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells
    Selak, Mary A., Durán, Raứl V., Gottlieb, Eyal · 2006 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
  42. Hidden features: exploring the non-canonical functions of metabolic enzymes
    Peiwei Huangyang, Marie Celeste Simon · 2018 · Disease Models & Mechanisms
  43. Molecular Biology of Renal Cell Cancer and the Identification of Therapeutic Targets
    Othon Iliopoulos · 2006 · Journal of Clinical Oncology
  44. The clinical implications of the genetics of renal cell carcinoma
    Inger L. Rosner, Gennady Bratslavsky, Peter A. Pinto, William Marston Linehan · 2009 · Urologic Oncology Seminars and Original Investigations
  45. Clinical implications of hypoxia inducible factor in renal cell carcinoma
    Marc C. Smaldone, Jodi Kathleen Maranchie · 2009 · Urologic Oncology Seminars and Original Investigations
  46. Mitochondria and Hypoxia: Metabolic Crosstalk in Cell-Fate Decisions
    Bargiela, David, Burr, Stephen P., Chinnery, Patrick F. · 2018 · Trends in Endocrinology & Metabolism
  47. Fumarate hydratase as a metabolic regulator of immunity
    Christian G. Peace, Shane M. O’Carroll, Luke A.J. O'Neill · 2023 · Trends in Cell Biology
  48. Fumarase: From the TCA Cycle to DNA Damage Response and Tumor Suppression
    Michael Leshets, Yardena Silas, Norbert Lehming, Ophry Pines · 2018 · Frontiers in Molecular Biosciences
  49. Redox Signaling from Mitochondria: Signal Propagation and Its Targets
    Petr Ježek, Blanka Holendová, Lydie Plecitá‐Hlavatá · 2020 · Biomolecules
  50. The role of glucose metabolism and glucose-associated signalling in cancer.
    Rainer Wittig, Johannes F. Coy · 2008 · PubMed Central
  51. Citric Acid Cycle Intermediates in Cardioprotection
    Gábor Czibik, Violetta Steeples, Arash Yavari, Houman Ashrafian · 2014 · Circulation Cardiovascular Genetics
  52. Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): A Contemporary Review and Practical Discussion of the Differential Diagnosis for HLRCC-Associated Renal Cell Carcinoma
    Stephanie L. Skala, Saravana Mohan Dhanasekaran, Rohit Mehra · 2018 · Archives of Pathology & Laboratory Medicine
  53. Signaling metabolite L-2-hydroxyglutarate activates the transcription factor HIF-1α in lipopolysaccharide-activated macrophages
    Niamh C. Williams, Dylan G. Ryan, Ana S.H. Costa, Evanna L. Mills, Mark P. Jedrychowski, Suzanne M. Cloonan, Christian Frezza, Luke A.J. O'Neill · 2021 · Journal of Biological Chemistry
  54. Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer
    Letizia Lanzetti · 2024 · Cell Death and Differentiation
  55. Extended Ischemia Prevents HIF1α Degradation at Reoxygenation by Impairing Prolyl-hydroxylation
    Anna Serra‐Pérez, Anna Maria Planas, Analía Núñez-O’Mara, Edurne Berra, Judit García‐Villoria, Antònia Ribes, Tomàs Santalucı́a · 2010 · Journal of Biological Chemistry
  56. Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered
    Shutao Zheng, Qing Liu, Tao Liu, Xiaomei Lu · 2021 · Journal of Physiology and Biochemistry
  57. Hypoxic Signalling in Tumour Stroma
    Anu Laitala, Janine Terra Erler · 2018 · Frontiers in Oncology
  58. Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma
    Munir Alrefae, Nora Wong, François Patenaude, Louis R. Bégin, William D. Foulkes · 2007 · Nature Clinical Practice Oncology
  59. Mitochondrial dysfunction, UPRmt signaling, and targeted therapy in metastasis tumor
    Rajendiran Keerthiga, De‐Sheng Pei, Ailing Fu · 2021 · Cell & Bioscience
  60. Metabolic alterations in hereditary and sporadic renal cell carcinoma
    Nathan J. Coffey, Marie Celeste Simon · 2024 · Nature Reviews Nephrology
  61. The role of mitochondria in the oncogenic signal transduction
    Christian Frezza · 2014 · The International Journal of Biochemistry & Cell Biology
  62. Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer
    Manop Pithukpakorn, M-H Wei, O Toure, P J Steinbach, G M Glenn, B Zbar, William Marston Linehan, J R Toro · 2006 · Journal of Medical Genetics
  63. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma
    Jun Wang, Ping Zhang, Jie Zhong, Mingyue Tan, Jifu Ge, Le Tao, Yakui Li, Yemin Zhu, Lifang Wu, Jianxin Qiu et al. · 2016 · Oncotarget
  64. Nitric Oxide Donor, (±)-S-Nitroso-N-acetylpenicillamine, Stabilizes Transactive Hypoxia-Inducible Factor-1α by Inhibiting von Hippel-Lindau Recruitment and Asparagine Hydroxylation
    Young-Kwon Park, Dae‐Ro Ahn, Myoungsuk Oh, Lee Tae-Kyoung, Eun Gyeong Yang, Miwon Son, Hyunsung Park · 2008 · Molecular Pharmacology
  65. Succinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and Epigenetics
    Yeng F. Her, Louis James Maher · 2015 · International Journal of Endocrinology
  66. Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC
    Toshinari Yamasaki, Tram Anh T. Tran, Orhan K. Öz, Ganesh V. Raj, Roderich Egbert Schwarz, Ralph J. DeBerardinis, Xuewu Zhang, James Brugarolas · 2011 · Nature Reviews Urology
  67. Reduced Expression of Fumarate Hydratase in Clear Cell Renal Cancer Mediates HIF-2α Accumulation and Promotes Migration and Invasion
    Sunil Sudarshan, Karthigayan Shanmugasundaram, Susan L. Naylor, Shu Lin, Carolina Becker Livi, Christine F. O’Neill, Dipen J. Parekh, I‐Tien Yeh, Lu‐Zhe Sun, Karen L. Block · 2011 · PLoS ONE
  68. Protein lysine acetylation guards metabolic homeostasis to fight against cancer
    Wei Xu, Ying Li, CHANWEI LIU, Shimin Zhao · 2013 · Oncogene
  69. Modulation of the Hypoxic Response
    Christopher William Pugh · 2016 · Advances in experimental medicine and biology
  70. Role of the mitochondrial stress response in human cancer progression
    Sheng‐Fan Wang, Shiuan Chen, Ling‐Ming Tseng, Hsin‐Chen Lee · 2020 · Experimental Biology and Medicine
  71. Targeted therapeutic strategies for the management of renal cell carcinoma
    Eric A. Singer, Gopal Nand Gupta, Ramaprasad Srinivasan · 2012 · Current Opinion in Oncology
  72. Genetic Basis of Cancer of the Kidney
    Sunil Sudarshan, William Marston Linehan · 2006 · Seminars in Oncology
  73. TATN-1 Mutations Reveal a Novel Role for Tyrosine as a Metabolic Signal That Influences Developmental Decisions and Longevity in Caenorhabditis elegans
    Annabel A. Ferguson, Sudipa Saha Roy, Kaitlyn Kormanik, Yong-Soon Kim, Kathleen J. Dumas, Vladimir B. Ritov, Dietrich Matern, Patrick J Hu, Alfred L. Fisher · 2013 · PLoS Genetics
  74. Evolving therapeutic targets in renal cell carcinoma
    Eric A. Singer, Gopal Nand Gupta, Daniel Marchalik, Ramaprasad Srinivasan · 2013 · Current Opinion in Oncology
  75. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using 18F-fluorodeoxyglucose-positron emission tomography/computed tomography
    Reiko Nakajima, Sayumi Nozaki, Tsunenori Kondo, Yoji Nagashima, Koichiro Abe, Shuji Sakai · 2017 · European Radiology
  76. Hypoxia-Inducible Factor Regulates Endothelial Metabolism in Cardiovascular Disease
    Karim Ullah, Rongxue Wu · 2021 · Frontiers in Physiology
  77. The role of PHD2 mutations in the pathogenesis of erythrocytosis
    Betty Gardie, Melanie J. Percy, David Hoogewijs, Rasheduzzaman Chowdhury, Celeste Bento, Mary Frances McMullin, Christopher John Schofield, Frank S. Lee, Stephane Richard, Patrick R. Arsenault et al. · 2014 · Hypoxia
  78. Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ‐coupled 2‐D LC‐MS/MS analysis: Insights on liver angiogenesis
    Jianhua Zhang, Dandan Niu, Jianjun Sui, Chi Bun Ching, Wei Ning Chen · 2009 · PROTEOMICS
  79. Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy
    Yan Long, Wen-Bin Tsai, Dajuan Wang, David H. Hawke, Niramol Savaraj, Lynn G. Feun, Mien‐Chie Hung, Helen H.W. Chen, Macus Tien Kuo · 2016 · Cancer Letters
  80. Immunometabolism: A new target for improving cancer immunotherapy
    Chunqing Guo, Shixian Chen, Wenjie Liu, Yibao Ma, Juan Li, Paul B. Fisher, Xianjun Fang, Xiang‐Yang Wang · 2019 · Advances in cancer research
  81. Fumarate Hydratase Deficiency and Cancer: Activation of Hypoxia Signaling?
    Peter John Ratcliffe · 2007 · Cancer Cell
  82. Erythropoietin
    Roland H. Wenger, Armin Kurtz · 2011 · Comprehensive physiology
  83. Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies
    Valentina Schiavoni, Monica Emanuelli, Giulio Milanese, Andrea Benedetto Galosi, Veronica Pompei, Eleonora Salvolini, Roberto Campagna · 2024 · International Journal of Molecular Sciences
  84. Metabolic and proteomic differentials in head and neck squamous cell carcinomas and normal gingival tissue
    Thomas Ziebart, Stefan Walenta, Martin Kunkel, Torsten E. Reichert, Wilfried Wagner, Wolfgang Mueller‐Klieser · 2010 · Journal of Cancer Research and Clinical Oncology
  85. The Skp1 Protein from Toxoplasma Is Modified by a Cytoplasmic Prolyl 4-Hydroxylase Associated with Oxygen Sensing in the Social Amoeba Dictyostelium
    Yuechi Xu, Kevin M. Brown, Zhuo A. Wang, Hanke van der Wel, Crystal Teygong, Dongmei Zhang, Ira J. Blader, Christopher M. West · 2012 · Journal of Biological Chemistry
  86. Metabolic Rewiring and the Characterization of Oncometabolites
    Diren Beyoğlu, Jeffrey R. Idle · 2021 · Cancers
  87. Obesity, Cholesterol, and Clear-Cell Renal Cell Carcinoma (RCC)
    Harry A. Drabkin, Robert M. Gemmill · 2010 · Advances in cancer research
  88. Oncometabolites in cancer aggressiveness and tumour repopulation
    Ilaria Dando, Elisa Dalla Pozza, Giulia Ambrosini, Margalida Torrens‐Mas, Giovanna Butera, Nidula Mullappilly, Raffaella Pacchiana, Marta Palmieri, Massimo Donadelli · 2019 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
  89. Transcription Association of VHL and SDH Mutations Link Hypoxia and Oxidoreductase Signals in Pheochromocytomas
    Patricia L. M. Dahia · 2006 · Annals of the New York Academy of Sciences
  90. Functional implications of fumarate-induced cysteine succination
    Iva Guberović, Christian Frezza · 2024 · Trends in Biochemical Sciences
  91. SIRT2 Interacts with β-Catenin to Inhibit Wnt Signaling Output in Response to Radiation-Induced Stress
    Phuongmai Nguyen, Sunmin Lee, Dominique Lorang-Leins, Jane B. Trepel, Dee Dee Smart · 2014 · Molecular Cancer Research
  92. Hydroxylase-dependent regulation of the NF-κB pathway
    Carsten C. Scholz, Cormac T. Taylor · 2013 · Biological Chemistry
  93. Intermediary Metabolite Precursor Dimethyl-2-Ketoglutarate Stabilizes Hypoxia-Inducible Factor-1α by Inhibiting Prolyl-4-Hydroxylase PHD2
    Peifeng Hou, Ching‐Ying Kuo, Chun-Ting Cheng, Jing‐Ping Liou, David Kong Ann, Qiang Chen · 2014 · PLoS ONE
  94. Hereditary and familial kidney cancer
    Jonathan Coleman, Paul Russo · 2009 · Current Opinion in Urology
  95. Critical role of TRPC6 in maintaining the stability of HIF-1α in glioma cells under hypoxia
    Shanshan Li, Jinkui Wang, Wei Yi, Yongjian Liu, Xia Ding, Bin Dong, Yinghui Xu, Yizheng Wang · 2015 · Journal of Cell Science
  96. Metabolite regulation of epigenetics in cancer
    Pu Wang, Leilei Chen, Yue Xiong, Dan Ye · 2024 · Cell Reports
  97. Leiomyoma Cutis: A Focused Review on Presentation, Management, and Association with Malignancy
    Kunal Malik, Parth Sudhendu Patel, Jin Chen, Amor Khachemoune · 2015 · American Journal of Clinical Dermatology
  98. Sensors, Transmitters, and Targets in Mitochondrial Oxygen Shortage—A Hypoxia-Inducible Factor Relay Story
    Nathalie Dehne, Bernhard Brüne · 2012 · Antioxidants and Redox Signaling
  99. Cell Metabolism Under Microenvironmental Low Oxygen Tension Levels in Stemness, Proliferation and Pluripotency
    M.P. Miguel, Yago Alcaina, Diego Sainz de la Maza, Pilar López-Iglesias · 2015 · Current Molecular Medicine
  100. The von Hippel‐Lindau Tumor Suppressor Protein: An Update
    William G. Kaelin · 2007 · Methods in enzymology on CD-ROM/Methods in enzymology